Pfizer and Moderna, the manufacturers of two of the most effective COVID-19 vaccines, have raised the prices of their jabs in their latest European Union (EU) supply contracts, according to a report in the Financial Times newspaper (FT).
Europe’s medicines watchdog said Friday it was checking whether Covid-19 vaccines made by Pfizer/BioNTech and Moderna could be linked to rare cases of blood clotting, but there was no indication so far.
US biotech firm Moderna on Monday announced its experimental vaccine against Covid-19 was 94.5 per cent effective, marking a second major breakthrough in the vaccine hunt.
The US biotech firm Moderna said Tuesday it would enter the final stage of its human trials for its COVID-19 vaccine on July 27, after promising early results were published in a journal. The Phase 3 trial will recruit 30,000 participants in the US, with half to receive the vaccine at 100 microgram dose levels, […]